Liposomal flucytosine capped with gold nanoparticle formulations for improved ocular delivery

References

• Juárez-VerdayesMAReyes-LópezMACancino-DiazMEIsolation, vancomycin resistance and biofilm production of Staphylococcus epidermidis from patients with conjunctivitis, corneal ulcers, and endophthalmitisRev Latinoam Microbiol2006483–423824618293657
   PubMedGoogle Scholar
• FosterASommerACorneal ulceration, measles, and childhood blindness in TanzaniaBr J Ophthalmol19877153313433580349
   PubMed Web of Science ®Google Scholar
• SrinivasanRKanungoRGoyalJLSpectrum of oculomycosis in South IndiaActa Ophthalmol (Copenh)19916967447491789089
   PubMed Web of Science ®Google Scholar
• KlotzSAPennCCNegveskyGJButrusSIFungal and parasitic infections of the eyeClin Microbiol Rev200013466268511023963
   PubMed Web of Science ®Google Scholar
• SridharJFlynnHWJrKuriyanAEMillerDAlbiniTEndogenous fungal endophthalmitis: risk factors, clinical features, and treatment outcomes in mold and yeast infectionsJ Ophthalmic Inflamm Infect2013316024053550
   PubMedGoogle Scholar
• NarendranNBalasubramaniamBJohnsonEDickAMayerEFive-year retrospective review of guideline-based management of fungal endophthalmitisActa Ophthalmol200886552553218752527
   PubMed Web of Science ®Google Scholar
• AxelrodAJPeymanGAIntravitreal amphotericin B treatment of experimental fungal endophthalmitisAm J Ophthalmol19737645845884582798
   PubMed Web of Science ®Google Scholar
• ChristmasNJSmiddyWEVitrectomy and systemic fluconazole for treatment of endogenous fungal endophthalmitisOphthalmic Surg Lasers19962712101210188976520
   PubMedGoogle Scholar
• YoshizumiMOBanihashemiARExperimental intravitreal ketoconazole in DMSORetina1988832102153266021
   PubMed Web of Science ®Google Scholar
• BlumenkranzMSStevensDATherapy of endogenous fungal endophthalmitis: miconazole or amphotericin B for coccidioidal and candidal infectionArch Ophthalmol1980987121612206967308
   PubMedGoogle Scholar
• KalavathyCMParmarPKaliamurthyJComparison of topical itraconazole 1% with topical natamycin 5% for the treatment of filamentous fungal keratitisCornea200524444945215829804
   PubMed Web of Science ®Google Scholar
• BreitSMHariprasadSMMielerWFShahGKMillsMDGrandMGManagement of endogenous fungal endophthalmitis with voriconazole and caspofunginAm J Ophthalmol2005139113514015652837
   PubMed Web of Science ®Google Scholar
• VermesAGuchelaarHJDankertJFlucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactionsJ Antimicrob Chemother200046217117910933638
   PubMed Web of Science ®Google Scholar
• PrausnitzMRNoonanJSPermeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eyeJ Pharm Sci199887121479148810189253
   PubMed Web of Science ®Google Scholar
• SchaefferHEKrohnDLLiposomes in topical drug deliveryInvest Ophthalmol Vis Sci19822222202277056633
   PubMed Web of Science ®Google Scholar
• CalvoPAlonsoMJVila-JatoJLRobinsonJRImproved ocular bioavailability of indomethacin by novel ocular drug carriersJ Pharm Pharmacol19964811114711528961163
   PubMed Web of Science ®Google Scholar
• ZhouYKongYKunduSCirilloJDLiangHAntibacterial activities of gold and silver nanoparticles against Escherichia coli and bacillus Calmette-GuérinJ Nanobiotechnology2012101922559747
   PubMed Web of Science ®Google Scholar
• ConnorEEMwamukaJGoleAMurphyCJWyattMDGold nano-particles are taken up by human cells but do not cause acute cytotoxicitySmall20051332532717193451
   PubMed Web of Science ®Google Scholar
• HauckTSGhazaniAAChanWCAssessing the effect of surface chemistry on gold nanorod uptake, toxicity, and gene expression in mammalian cellsSmall20084115315918081130
   PubMed Web of Science ®Google Scholar
• FrensGControlled nucleation for the regulation of the particle size in monodisperse gold suspensionsNature19732411052022
   Web of Science ®Google Scholar
• FrensGParticle size and sol stability in metal colloidsColloid Polym Sci19722507736741
   Google Scholar
• NguyenDTKimDJKimKSControlled synthesis and biomolecular probe application of gold nanoparticlesMicron201142320722720952201
   PubMed Web of Science ®Google Scholar
• SunKQiuJLiuJMiaoYPreparation and characterization of gold nanoparticles using ascorbic acid as reducing agent in reverse micellesJ Mater Sci2009443754758
   Web of Science ®Google Scholar
• TorchilinVWeissigVLiposomes: A Practical Approach2nd edNew YorkOxford University Press2003
   Google Scholar
• DemersLMMirkinCAMucicRCA fluorescence-based method for determining the surface coverage and hybridization efficiency of thiol-capped oligonucleotides bound to gold thin films and nanoparticlesAnal Chem200072225535554111101228
   PubMed Web of Science ®Google Scholar
• ColasJCShiWRaoVSOmriAMozafariMRSinghHMicroscopical investigations of nisin-loaded nanoliposomes prepared by Mozafari method and their bacterial targetingMicron200738884184717689087
   PubMed Web of Science ®Google Scholar
• HaoYZhaoFLiNYangYLiKStudies on a high encapsulation of colchicine by niosome systemInt J Pharm20022441–2738012204566
   PubMed Web of Science ®Google Scholar
• du PlessisJRamachandranCWeinerNMüllerDGThe influence of lipid composition and lamellarity of liposomes on the physical stability of liposomes upon storageInt J Pharm19961272273278
   Google Scholar
• MatarMJOstrosky-ZeichnerLPaetznickVLRodriguezJRChenERexJHCorrelation between E-test, disk diffusion, and microdilution methods for antifungal susceptibility testing of fluconazole and voriconazoleAntimicrob Agents Chemother20034751647165112709335
   PubMed Web of Science ®Google Scholar
• HelsinkiFResponsibility in Investigations on Human Subjects: M.R.C. StatementBr Med J19642540217818014150899
   PubMedGoogle Scholar
• MilisitsGRomváriRZotteADSzendrőZNon-invasive study of changes in body composition in rabbits during pregnancy using X-ray computerized tomographyAnn Zootech1999482534
   Google Scholar
• BuryRWMashfordMLMilesHMAssay of flucytosine (5-fluorocytosine) in human plasma by high-pressure liquid chromatographyAntimicrob Agents Chemother1979165529532525993
   PubMed Web of Science ®Google Scholar
• WuTGWilhelmusKRMitchellBMExperimental keratomycosis in a mouse modelInvest Ophthalmol Vis Sci200344121021612506077
   PubMed Web of Science ®Google Scholar
• PeruginiPPavanettoFLiposomes containing boronophenylalanine for boron neutron capture therapyJ Microencapsul19981544734839651869
   PubMed Web of Science ®Google Scholar
• SrinathPVyasSPDiwanPVPreparation and pharmacodynamic evaluation of liposomes of indomethacinDrug Dev Ind Pharm200026331332110738648
   PubMed Web of Science ®Google Scholar
• HathoutRMMansourSMortadaNDGuinediASLiposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studiesAAPS Pharm Sci Tech2007811
   PubMed Web of Science ®Google Scholar
• NagarsenkerMSLondheVYNadkarniGDPreparation and evaluation of liposomal formulations of tropicamide for ocular deliveryInt J Pharm19991901637110528098
   PubMed Web of Science ®Google Scholar
• HosnyKMCiprofloxacin as ocular liposomal hydrogelAAPS Pharm Sci Tech2010111241246
   PubMed Web of Science ®Google Scholar
• XuXYuZZhuYWangBEffect of sodium oleate adsorption on the colloidal stability and zeta potential of detonation synthesized diamond particles in aqueous solutionsDiam Relat Mater2005142206212
   Web of Science ®Google Scholar
• RiddickTMControl of Colloid Stability through Zeta PotentialLivingston Publishing CompanyWynnewood, Pennsylvania1968
   Google Scholar
• AmirTFatmaAHakanAGold Nanoparticle Synthesis and CharacterisationHacettepe J Biol Chem2009373217226
   Google Scholar
• SureewanDBoonnadaPPraneetORole of the charge, carbon chain length, and content of surfactant on the skin penetration of meloxicam-loaded liposomesInt J Nanomedicine201492005201724851047
   PubMed Web of Science ®Google Scholar
• CrommelinDJInfluence of lipid composition and ionic strength on the physical stability of liposomesJ Pharm Sci19847311155915636520758
   PubMed Web of Science ®Google Scholar
• HiguchiTMechanism of sustained-action medication: theoretical analysis of rate of release of solid drugs dispersed in solid matricesJ Pharm Sci196352121145114914088963
   PubMed Web of Science ®Google Scholar
• El-SamaligyMSAfifiNNMahmoudEAIncreasing bioavail-ability of silymarin using a buccal liposomal delivery system: preparation and experimental design investigationInt J Pharm20063081–214014816356669
   PubMed Web of Science ®Google Scholar
• MargalitROkonMYerushalmiNAvidorEBioadhesive liposomes as topical drug delivery systems: molecular and cellular studiesJ Control Release1992191–3275287
   Google Scholar
• MargalitRAlonRLinenbergMRubinIRosemanTJWoodRWLiposomal drug delivery: thermodynamic and chemical kinetic considerationsJ Control Release1991173285296
   Web of Science ®Google Scholar
• ParkSHOhSGMunJYHanSSLoading of gold nanoparticles inside the DPPC bilayers of liposome and their effects on membrane fluiditiesColloids Surf B Biointerfaces200648211211816520025
   PubMed Web of Science ®Google Scholar
• Hernández-CasellesTVillalaínJGómez-FernándezJCStability of liposomes on long term storageJ Pharm Pharmacol19904263974001979618
   PubMed Web of Science ®Google Scholar
• PatelVBMisraANEncapsulation and stability of clofazimine liposomesJ Microencapsul199916335736710340220
   PubMed Web of Science ®Google Scholar
• RükanGMayreliOCiaraKODiffusion-controlled synthesis of gold nanoparticles: nano-liposomes as mass transfer barrierJ Nanopart Res201416415
   Web of Science ®Google Scholar
• TanYNLeeKHSuXStudy of single-stranded DNA binding protein-nucleic acids interactions using unmodified gold nanoparticles and its application for detection of single nucleotide polymorphismsAnal Chem201183114251425721524056
   PubMed Web of Science ®Google Scholar
• Cunha-VazJGThe blood-ocular barriers: past, present, and futureDoc Ophthalmol1997931–21491579476613
   PubMed Web of Science ®Google Scholar
• NakanoYMuroSSakaiHComputed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung functionAm J Respir Crit Care Med20001623 Pt 11102110810988137
   PubMed Web of Science ®Google Scholar
• de la ZerdaAPrabhulkarSPerezVLOptical coherence contrast imaging using gold nanorods in living mice eyesClin Experiment Ophthalmol201543435836624533647
   PubMed Web of Science ®Google Scholar
• KlangSAbdulrazikMBenitaSInfluence of emulsion droplet surface charge on indomethacin ocular tissue distributionPharm Dev Technol20005452153211109251
   PubMed Web of Science ®Google Scholar
• VermaDDVermaSBlumeGFahrAParticle size of liposomes influences dermal delivery of substances into skinInt J Pharm20032581–214115112753761
   PubMed Web of Science ®Google Scholar
• El-GazayerlyONHikalAHPreparation and evaluation of acetazolamide liposomes as an ocular delivery systemInt J Pharm19971582121127
   Web of Science ®Google Scholar
• SinghKMezeiMLiposomal ophthalmic drug delivery system I. Triamcinolone acetonideInt J Pharm1983163339344
   Google Scholar
• SinghKMezeiMLiposomal ophthalmic drug delivery system. II. Dihydrostreptomycin sulfateInt J Pharm1984193263269
   Google Scholar
• LeeVHUrreaPTSmithRESchazlinDJOcular drug bioavailability from topically applied liposomesSurv Ophthalmol19852953353483992472
   PubMed Web of Science ®Google Scholar
• ScholerHJFlucytosineSpellerDCEAntifungal chemotherapyNew YorkWiley198035106
   Google Scholar
• ChenYZhengXXieYDingCRuanHFanCAnti-bacterial and cytotoxic properties of plasma sprayed silver-containing HA coatingsJ Mater Sci Mater Med200819123603360918642059
   PubMed Web of Science ®Google Scholar
• EidKAMSalemHFZikryAAFEl-SayedAFMSharafMAAnti-fungal Effects of Colloidally Stabilized Gold Nanoparticles: Screening by Microplate AssayNature and Science2011922933
   Google Scholar
• ChenHDorriganASaadSHareDJCortieMBValenzuelaSMIn vivo study of spherical gold nanoparticles: inflammatory effects and distribution in micePloS One201382e5820823469154
   PubMed Web of Science ®Google Scholar
• ShenoyDFuWLiJSurface functionalization of gold nano-particles using hetero-bifunctional poly(ethylene glycol) spacer for intracellular tracking and deliveryInt J Nanomedicine200611515716467923
   PubMed Web of Science ®Google Scholar
• ThassuDChaderGJOcular Drug Delivery Systems: Barriers and Application of Nanoparticulate SystemsCRC Press2012
   Google Scholar
• NiidomeTYamagataMOkamotoYPEG-modified gold nano-rods with a stealth character for in vivo applicationsJ Control Release2006114334334716876898
   PubMed Web of Science ®Google Scholar
• KimJHKimKWKimMHYuYSIntravenously administered gold nanoparticles pass through the blood-retinal barrier depending on the particle size, and induce no retinal toxicityNanotechnology2009205050510119923650
   PubMed Web of Science ®Google Scholar
• GuinediASMortadaNDMansourSHathoutRMPreparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamideInt J Pharm20053061–2718216263229
   PubMed Web of Science ®Google Scholar
• PandeyVPDeivasigamaniKPreparation and characterization of ofloxacin non-ionic surfactant vesicles for ophthalmic useJ Pharm Res20092813301334
   Google Scholar
• PepićIHafnerALovrićJPirkićBFilipović-GrcićJA nonionic surfactant/chitosan micelle system in an innovative eye drop formulationJ Pharm Sci201099104317432520310026
   PubMed Web of Science ®Google Scholar
• KaurIPRanaCSinghMBhushanSSinghHKakkarSDevelopment and evaluation of novel surfactant-based elastic vesicular system for ocular delivery of fluconazoleJ Ocul Pharmacol Ther201228548449622694593
   PubMed Web of Science ®Google Scholar
• DubeyAPrabhuPDevelopment and investigation of Niosomes of Brimonidine tartrate and Timolol maleate for the treatment of glaucomaInt J Pharmtech Res201463942950
   Google Scholar
• HuCRhodesDGProniosomes: a novel drug carrier preparationInt J Pharm19991851233510425362
   PubMed Web of Science ®Google Scholar
• JiaoJPolyoxyethylated nonionic surfactants and their applications in topical ocular drug deliveryAdv Drug Deliv Rev200860151663167318845195
   PubMed Web of Science ®Google Scholar
• BochotaAMashhourBPuisieuxFCouvreurPFattalEComparison of the ocular distribution of a model oligonucleotide after topical instillation in rabbits of conventional and new dosage formsJ Drug Target1998643093139894698
   PubMed Web of Science ®Google Scholar